Impact of Chinese national centralized volume-based drug procurement policy on health costs and utilization: An interrupted time series analysis using panel data (2009–2022)
Yishi Jiang,
Guangsheng Wan,
Yufeng Shi,
Guiping Pu and
Xiaojun Shao
PLOS ONE, 2025, vol. 20, issue 12, 1-17
Abstract:
Introduction: Chinese volume-based procurement (VBP) policy, implemented nationally in 2019, represents a cornerstone of healthcare reform aiming to reduce drug prices through centralized drug procurement. While existing studies have demonstrated the success of the VBP policy in lowering drug costs, comprehensive assessments of system-wide impacts on healthcare expenditures and service utilization remain underexplored. This study evaluates its effects on outpatient and inpatient service costs and volumes. Materials and methods: We conducted an interrupted time series analysis using panel data (2009–2022) from the China Health Statistical Yearbook and the China Statistical Yearbook. Primary outcomes included CPI(Consumer Price Index)-adjusted per-visit outpatient(OP)/inpatient(IP) expenditures, hospital OP rates, hospital IP rates, and length of stay. Segmented regression models quantified immediate and long-term policy effects, with two-stage meta-analysis evaluating regional heterogeneity. Results and discussion: When the VBP implementation occurred, per-visit outpatient costs (β2 = 21.400, P
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0338409 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 38409&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0338409
DOI: 10.1371/journal.pone.0338409
Access Statistics for this article
More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().